三元股份(600429.SH)擬1.002億元收購艾萊發喜5%股權
格隆匯6月8日丨三元股份(600429.SH)公佈,北京艾萊發喜食品有限公司(簡稱“艾萊發喜”)為公司控股子公司,公司持有其90%的股權,北京艾萊宏達商貿有限公司(簡稱“艾萊宏達”)持有其10%的股權。公司擬收購艾萊宏達持有的艾萊發喜5%股權,交易價格1.002億元。
截至2019年12月31日,艾萊發喜總資產10.076億元,淨資產6.78億元,2019年實現營業收入14.37億元,淨利潤9794萬元。
本次股權轉讓前,公司持有艾萊發喜90%的股權,艾萊宏達持有艾萊發喜10%的股權。本次股權轉讓完成後,公司持有艾萊發喜95%的股權,艾萊宏達持有艾萊發喜5%的股權。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.